Search Results

You are looking at 111 - 120 of 912 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

Stanton L. Gerson, Kate Shaw, Louis B. Harrison, Randall F. Holcombe, Laura Hutchins, Carrie B. Lee, Patrick J. Loehrer Sr, Daniel Mulkerin, W. Thomas Purcell, Lois Teston, Louis M. Weiner, and George J. Weiner

Background: Cancer care coordination across major academic medical centers and their networks is evolving rapidly, but the spectrum of organizational efforts has not been described. We conducted a mixed-methods survey of leading cancer centers and their networks to document care coordination and identify opportunities to improve geographically dispersed care. Methods: A mixed-methods survey was sent to 91 cancer centers in the United States and Canada. We analyzed the number and locations of network sites; access to electronic medical records (EMRs); clinical research support and participation at networks; use of patient navigators, care paths, and quality measures; and physician workforce. Responses were collected via Qualtrics software between September 2017 and December 2018. Results: Of the 69 responding cancer centers, 74% were NCI-designated. Eighty-seven percent of respondents were part of a matrix health system, and 13% were freestanding. Fifty-six reported having network sites. Forty-three respondents use navigators for disease-specific populations, and 24 use them for all patients. Thirty-five respondents use ≥1 types of care path. Fifty-seven percent of networks had complete, integrated access to their main center’s EMRs. Thirty-nine respondents said the main center provides funding for clinical research at networks, with 22 reporting the main center provides all funding. Thirty-five said the main center provided pharmacy support at the networks, with 15 indicating the main center provides 100% pharmacy support. Certification program participation varied extensively across networks. Conclusions: The data show academic cancer centers have extensive involvement in network cancer care, often extending into rural communities. Coordinating care through improved clinical trial access and greater use of patient navigation, care paths, coordinated EMRs, and quality measures is likely to improve patient outcomes. Although it is premature to draw firm conclusions, the survey results are appropriate for mapping next steps and data queries.

Full access

Rodger J. Winn

Full access

NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities The NCCN Oncology Research Program (ORP) has established the NCCN Affiliate Research Consortium (ARC). The NCCN ARC’s primary goal is to

Full access

Melissa A. Simon, Laura S. Tom, and XinQi Dong

policymakers, other leaders, and, most importantly, communities, including those who are differentially impacted by these messages. Our concern with this article is that in the absence of additional angles and levels of analyses, these ecological data provide

Full access

Kendra L. Ratnapradipa, Jordan Ranta, Krishtee Napit, Lady Beverly Luma, Danae Dinkel, Tamara Robinson, Laura Schabloske, and Shinobu Watanabe-Galloway

Purpose : To explore rural cancer survivors’ and caregivers’ experiences with diagnosis and treatment, and to identify needed support services. Methods : This collective case study was part of a statewide cancer community health needs

Full access

Eliza Wright Beal, Leva Gorji, Jaclyn Volney, Lindsey Sova, Ann McAlearney, and Allan Tsung

invite primary care providers from the Departments of Internal Medicine and Family and Community Medicine and specialty providers from the Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, to participate. A semi

Full access

Reshma Mahtani, Alex Niyazov, MPH; Katie Lewis, Lucy Massey, Alex Rider, Bhakti Arondekar, and Michael Lux

[HR+/HER2− vs triple-negative breast cancer (TNBC)], practice setting (academic vs community) and type of BRCA1/2 mut test and compared via Fisher’s exact tests. Results: Overall, 407 pts were included; the mean age was 64.2 years, and 99% were

Full access

. Continued communication between NCCN, NCCN Member Institutions, users of NCCN products and services, community, lay and professional organizations, providers, payers, and industry will serve us all well. Please never hesitate to contact those of us at NCCN

Full access

Alexandra K. Zaleta, Melissa F. Miller, Erica E. Fortune, Kelly A. Clark, and Elissa C. Kranzler

). We evaluated the psychometric performance of CSS-CG depression (CSS-D2) and anxiety (CSS-A2) risk screening subscales among community-based family and informal caregivers. Methods: 328 cancer caregivers enrolled in Cancer Support Community’s Cancer

Full access

cancer community and reduce socioeconomic-related cancer disparities. This prospective study will evaluate the effectiveness of CommunityRx-Cancer (CRx-Can). CRx-Can is an innovative, multilevel IT-enhanced patient navigation intervention that engages